» Articles » PMID: 11466024

Levetiracetam Does Not Modulate Neuronal Voltage-gated Na+ and T-type Ca2+ Currents

Overview
Journal Seizure
Publisher Elsevier
Specialty Neurology
Date 2001 Jul 24
PMID 11466024
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

This study investigated whether the mechanism of action of levetiracetam (LEV) is related to effects on neuronal voltage-gated Na+ or T-type Ca2+currents. Rat neocortical neurones in culture were subjected to the whole-cell mode of voltage clamping under experimental conditions designed to study voltage-gated Na+ current. Additionally, visually identified pyramidal neurones in the CA1 area of rat hippocampal slices were subjected to the whole-cell mode of voltage clamping under experimental conditions designed to study low-voltage-gated (T-type) Ca2+ current. LEV (10 microM-1 mM) did not modify the Na+ current amplitude and did not change (200 microM) the steady-state activation and inactivation, the time to peak, the fast kinetics of the inactivation and the recovery from the steady-state inactivation of the Na+ current. Likewise, LEV (32-100 microM) did not modify the amplitude and did not change the steady-state activation and inactivation, the time to peak, the fast kinetics of the inactivation and the recovery from the steady-state inactivation of the T-type Ca2+current. In conclusion, neuronal voltage-gated Na+ channels do not appear directly involved in the antiepileptic mechanism of action of LEV, and LEV was devoid of effect on the low-voltage-gated (T-type) Ca2+ current in hippocampal neurones.

Citing Articles

Changes in the Dentate Gyrus Gene Expression Profile Induced by Levetiracetam Treatment in Rats with Mesial Temporal Lobe Epilepsy.

Diaz-Villegas V, Pichardo-Macias L, Juarez-Mendez S, Ignacio-Mejia I, Cardenas-Rodriguez N, Antonio Vargas-Hernandez M Int J Mol Sci. 2024; 25(3).

PMID: 38338984 PMC: 10855401. DOI: 10.3390/ijms25031690.


Development of SV2A Ligands for Epilepsy Treatment: A Review of Levetiracetam, Brivaracetam, and Padsevonil.

Wu P, Cao B, Tian F, Gao Z Neurosci Bull. 2023; 40(5):594-608.

PMID: 37897555 PMC: 11127901. DOI: 10.1007/s12264-023-01138-2.


Cardiac morbidity and mortality associated with the use of lamotrigine.

Christensen J, Trabjerg B, Dreier J Epilepsia. 2022; 63(9):2371-2380.

PMID: 35735211 PMC: 9796304. DOI: 10.1111/epi.17339.


Treatment with levetiracetam improves cognition in a ketamine rat model of schizophrenia.

Koh M, Shao Y, Rosenzweig-Lipson S, Gallagher M Schizophr Res. 2017; 193:119-125.

PMID: 28634087 PMC: 5733713. DOI: 10.1016/j.schres.2017.06.027.


Levetiracetam inhibits oligomeric Aβ-induced glutamate release from human astrocytes.

Sanz-Blasco S, Pina-Crespo J, Zhang X, McKercher S, Lipton S Neuroreport. 2016; 27(9):705-9.

PMID: 27183239 PMC: 4874889. DOI: 10.1097/WNR.0000000000000601.